Oncology

Delivering global market research insights in oncology

Oncology is one of the most exciting and fast-moving therapy areas to be working in today, with better detection of cancer and better treatments both contributing to improved patient outcomes. Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. Clinical trials of emerging products, both alone and in combination, have delivered impressive evidence of improvements in overall survival, progression-free survival tolerability, and duration of response. Consequently, the major pharmaceutical companies’ R&D pipelines are now filled with immuno-oncology prospects across a wide range of indications. 

However, these therapies come with a very high price tag and only a proportion of patients are currently responsive to the checkpoint inhibitors showing most promise. The ability to identify appropriate patient sub-groups through predictive biomarkers and other forms of testing are critical to ensure the most effective use of these treatments. The approval of immunotherapies across multiple indications means that pharma marketers need to develop strong pan-tumour strategies for their brands.

Research Partnership understands oncology. One in five of the projects we manage is in this therapy area and we appreciate the complexities and fast-moving nature of the market. We can help you with:

  • Market and competitor understanding

  • Opportunity and demand assessment

  • Pricing and market access

  • Patient segmentation

  • Product and portfolio development

  • Brand positioning, launch and beyond

We have experience across solid and non-solid tumours, including but not limited to: breast cancer, skin cancer, colo-rectal cancer, renal cancer, prostate cancer, lung cancer and blood cancers.

Syndicated research

Our custom research is complemented by global market intelligence delivered by our real-time market tracking tool, Therapy Watch. We are building panels in specific oncology indications and can supplement your market understanding.

Oncology resources:

How 360 qualitative insights gave strategic direction into the development of an oncology biomarker

Case study

How 360 qualitative insights gave strategic direction into the development of an oncology biomarker.

Learn more

How a mobile research approach delivered new insights into physicians’ prescribing decisions

Case study

How a mobile research approach delivered new insights into physicians’ prescribing decisions.

Learn more

Oncology infogrpahic small resource image

Infographic

Find out about our experience and expertise in delivering global market research insights in Oncology.

View

Combination therapies in Oncology (May 2018)

Webcast

Combination therapies in oncology: The benefits of integrated insights.

Watch